Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Mazagon Dock Shipbuilders reaches 52-week high after Acquiring Navratna Status

    Mazagon Dock Shipbuilders reaches 52-week high after Bagging 'Navratna' Status


    Finance Outlook India Team | Wednesday, 26 June 2024

    Mazagon Dock Shipbuilders' shares rose 7.36%, reaching a 52-week high of Rs 4269.75 a share on the BSE in early morning trading on Wednesday. The stock fell to a 52-week low of Rs 1,223.05 on June 27, 2023.

    However, today's increase in stock price occurred after the business received "Navratna" status from the Department of Public Enterprises, making it India's 18th Public Sector Undertaking (PSU) to receive this designation. With its recent financial performance, the firm has entered the ranks of other Navratna Indian companies, including NMDC, RVNL, IRCON, and IREDA, among others. 

    Mazagon Dock Shipbuilders Limited

    Mazagon Dock, being a Navratna firm, can undertake investments of up to Rs 1,000 crore without obtaining national government clearance. These corporations can also invest up to 30% of their net worth in a single year, provided it does not exceed Rs 1,000 crore.

    Furthermore, Navratna designation allows Mazagon Dock to form joint ventures, alliances, and establish subsidiaries abroad, giving them more freedom and autonomy in their commercial operations.

    To acquire Navratna status, a corporation must meet stringent financial criteria for three consecutive years. This includes generating a net profit of more than Rs 5,000 crore per year, sustaining an average yearly revenue of Rs 25,000 crore, or exhibiting an average annual net worth more than Rs 15,000 crore.

    Mazagon Dock Shipbuilders, the state-run ship maker, showed strong financial increase in the March quarter over the previous year. The company's revenue increased by 50% to Rs 3,103.6 crore from Rs 2,078.6 crore in the same period last year. Net profit more than doubled to Rs 663 crore, up from Rs 326 crore a year earlier. At 09:48 PM, the company's share price had reduced some of its gains and was 4.49 percent higher at Rs 4155 per share on the BSE. In comparison, the BSE Sensex was trading flat, 0.05 percent higher. The company's shares are currently selling at a 43.46 price-to-earnings multiple, with an earnings per share of Rs 91.50.



    Read More:

    Piyush Goyal Announces Rs 10,000 Crore Fund of Funds for Startups

    Ashika Institutional, MOFSL & Bajaj Broking Markets Closing Commentary

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us